| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/12/2004 | EP1416936A1 Thiopyrane-4-ones as dna protein kinase inhibitors |
| 05/12/2004 | EP1416935A1 4-amino-6-phenyl-pyrrolo 2,3-d]pyrimidine derivatives |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416932A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416930A1 Pramipexole for the treatment of adhd |
| 05/12/2004 | EP1416929A2 Cancer treatment with gö6976 and its related compounds |
| 05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 05/12/2004 | EP1416927A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 05/12/2004 | EP1416916A1 Chitin microparticles and their medical uses |
| 05/12/2004 | EP1416907A1 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 05/12/2004 | EP1416885A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 05/12/2004 | EP1416884A2 Delivery of therapeutic capable agents |
| 05/12/2004 | EP1416795A1 Compositions and methods for treatment of mitochondrial diseases |
| 05/12/2004 | EP1345936B1 Method for producing the anticholinergic agent tiotropium bromide |
| 05/12/2004 | EP1303284A4 Compositions and methods for the treatment of skin damage |
| 05/12/2004 | EP1218352B1 Benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 05/12/2004 | EP1208095B1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1152753B1 Combinations of formoterol and fluticasone propionate for asthma |
| 05/12/2004 | EP1146863B1 Lyophilisates with improved reconstitutibility |
| 05/12/2004 | EP1131067B1 Composition and use of rar antagonists for promoting chondrogenesis |
| 05/12/2004 | EP1119254A4 Novel treatment for stroke management |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1102592B1 Coumarin and related aromatic-based polymeric prodrugs |
| 05/12/2004 | EP1100497B1 Heterocyclyl sulphonamide derivatives |
| 05/12/2004 | EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 05/12/2004 | EP1058559B1 Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP1007556B1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0891346B1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | CN1496405A Processer for enhanced production of pantothenate |
| 05/12/2004 | CN1496366A Triazolopyridines as anti-inflammatory agents |
| 05/12/2004 | CN1496364A Substituted quinazoline derivatives and their use as inhibitors |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496361A 苯基衍生物3 Phenyl derivative 3 |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1496265A Medicine for fighting against sexual dysfunction |
| 05/12/2004 | CN1496264A 4-fluoro-N-indan-2-Y1 benzamide and its use as pharmaceutical |
| 05/12/2004 | CN1496263A Use of anfigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 05/12/2004 | CN1496262A Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 05/12/2004 | CN1496260A Method for increasing leptin levels using nicotinic acid compounds |
| 05/12/2004 | CN1496259A New use |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases |
| 05/12/2004 | CN1496255A Inhibition of NF-KB by triterpene compositions |
| 05/12/2004 | CN1496253A 新组合物 The new composition |
| 05/12/2004 | CN1495198A Analogs of glucagon-like peptide-1 |
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1495172A Irreversible inhibitor of tyrosine kinase |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1495166A Organic acid salt of amlodipine |
| 05/12/2004 | CN1495165A Indane or indoline derivative |
| 05/12/2004 | CN1495163A Novol pyrrole sulphamide compound |
| 05/12/2004 | CN1494923A Medicine capable of repairing human body gene for curing diseases and its preparation method. |
| 05/12/2004 | CN1494903A Preventing or curing agent for eye fatigue and pseudomyopia |
| 05/12/2004 | CN1149215C Phenyl Yanthine derivatives |
| 05/12/2004 | CN1149214C Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/12/2004 | CN1149212C Peperidine derivatives as reuptake inhibitors |
| 05/12/2004 | CN1149210C Thrombin inhibitors |
| 05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
| 05/12/2004 | CN1149201C Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149195C 5-HTIF agonists |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149088C Bone growth promoting composition and its use |
| 05/12/2004 | CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas |
| 05/12/2004 | CN1149083C Pharmaceutical compositions containing irbesartan |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/12/2004 | CN1149080C Prilocaine and hydrofluorocarbon aerosol preparations |
| 05/11/2004 | US6734307 Use against multiply resistant gram positive pathogens; have a diazine moiety attached to the phenyloxazolidinone which is further substituted by heterocyclic, aryl, substituted aryl, heteroaroamatic ring |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734302 Cis-imidazolines |
| 05/11/2004 | US6734301 2,3,4,5-Tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds |
| 05/11/2004 | US6734300 Purification using cationic ion exchange resins |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734286 Interleukin-5 specific recombinant antibodies |
| 05/11/2004 | US6734204 Permit selective modulation of or even have opposing effects on different serotonin receptor subtypes |
| 05/11/2004 | US6734199 Such as n-((4-benzyloxyphenyl)-methyl)-5-((2,4-dioxothiazolidin-5-yl)methyl)-2 -methoxybenzamide, hypoglycemic and lipid lowering effect via peroxisome proliferator-activated receptor |
| 05/11/2004 | US6734194 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734179 Sulfur compounds such as 4-fluoro-n-(4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl) -benzamide, used as preferential adenosine receptor ligands for the prophylaxis of neurodegenerative disorders |
| 05/11/2004 | US6734175 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor |
| 05/11/2004 | US6734169 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 05/11/2004 | US6734168 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734003 Phosphodiesterase 10 |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733978 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |